1. Home
  2. NTST vs ELVN Comparison

NTST vs ELVN Comparison

Compare NTST & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTST
  • ELVN
  • Stock Information
  • Founded
  • NTST 2019
  • ELVN 2016
  • Country
  • NTST United States
  • ELVN United States
  • Employees
  • NTST N/A
  • ELVN N/A
  • Industry
  • NTST Real Estate Investment Trusts
  • ELVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • NTST Real Estate
  • ELVN Health Care
  • Exchange
  • NTST Nasdaq
  • ELVN Nasdaq
  • Market Cap
  • NTST 1.3B
  • ELVN 1.2B
  • IPO Year
  • NTST 2020
  • ELVN 2020
  • Fundamental
  • Price
  • NTST $16.81
  • ELVN $21.91
  • Analyst Decision
  • NTST Strong Buy
  • ELVN Strong Buy
  • Analyst Count
  • NTST 8
  • ELVN 5
  • Target Price
  • NTST $18.16
  • ELVN $41.20
  • AVG Volume (30 Days)
  • NTST 887.5K
  • ELVN 715.9K
  • Earning Date
  • NTST 07-23-2025
  • ELVN 08-12-2025
  • Dividend Yield
  • NTST 5.00%
  • ELVN N/A
  • EPS Growth
  • NTST N/A
  • ELVN N/A
  • EPS
  • NTST N/A
  • ELVN N/A
  • Revenue
  • NTST $171,021,000.00
  • ELVN N/A
  • Revenue This Year
  • NTST $12.84
  • ELVN N/A
  • Revenue Next Year
  • NTST $6.47
  • ELVN N/A
  • P/E Ratio
  • NTST N/A
  • ELVN N/A
  • Revenue Growth
  • NTST 22.05
  • ELVN N/A
  • 52 Week Low
  • NTST $13.42
  • ELVN $13.30
  • 52 Week High
  • NTST $17.53
  • ELVN $30.03
  • Technical
  • Relative Strength Index (RSI)
  • NTST 58.16
  • ELVN 53.09
  • Support Level
  • NTST $16.85
  • ELVN $19.38
  • Resistance Level
  • NTST $17.20
  • ELVN $21.34
  • Average True Range (ATR)
  • NTST 0.33
  • ELVN 1.16
  • MACD
  • NTST -0.01
  • ELVN -0.17
  • Stochastic Oscillator
  • NTST 63.66
  • ELVN 48.14

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: